Connection

Ji Lee to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications Ji Lee has written about Clinical Trials, Phase II as Topic.
Ji Lee
Connection Strength
0.037
Clinical Trials, Phase II as Topic
  1. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial. Trials. 2019 Jan 16; 20(1):57.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.